Global HIV Epidemiology and Patient Flow Analysis 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Global HIV Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

This research provides insights into HIV epidemiology, HIV diagnosed patients, and HIV treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of HIV derived from epidemiological analysis, patients diagnosed with HIV, and patients treated with a drug therapy.

The research study helps executives estimate HIV market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of HIV prevalence, HIV diagnosis rate, and HIV treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Highlights

  • HIV Patient Flow
  • HIV Prevalence
  • HIV Diagnosed Patients
  • HIV Treated Patients

Key Topics Covered

1. HIV: Disease Definition

2. Global HIV Patient Flow

2A. Global HIV Prevalence

2B. Global HIV Diagnosed Patients

2C. Global HIV Treated Patients

3. HIV Patient Flow in the US

3A. HIV Prevalence in the US

3B. HIV Diagnosed Patients in the US

3C. HIV Treated Patients in the US

4. HIV Patient Flow in Europe

4A. HIV Prevalence in Europe

4B. HIV Diagnosed Patients in Europe

4C. HIV Treated Patients in Europe

5. HIV Patient Flow in Germany

5A. HIV Prevalence in Germany

5B. HIV Diagnosed Patients in Germany

5C. HIV Treated Patients in Germany

6. HIV Patient Flow in France

6A. HIV Prevalence in France

6B. HIV Diagnosed Patients in France

6C. HIV Treated Patients in France

7. HIV Patient Flow in Spain

7A. HIV Prevalence in Spain

7B. HIV Diagnosed Patients in Spain

7C. HIV Treated Patients in Spain

8. HIV Patient Flow in Italy

8A. HIV Prevalence in Italy

8B. HIV Diagnosed Patients in Italy

8C. HIV Treated Patients in Italy

9. HIV Patient Flow in UK

9A. HIV Prevalence in UK

9B. HIV Diagnosed Patients in UK

9C. HIV Treated Patients in UK

10. HIV Patient Flow in Japan

10A. HIV Prevalence in Japan

10B. HIV Diagnosed Patients in Japan

10C. HIV Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/wrppp8/global_hiv?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: HIV/AIDS Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: HIV/AIDS Drugs